Related Experiment Video
Updated: Jul 17, 2026

Preclinical Assessment of the Bioactivity of the Anticancer Coumarin OT48 by Spheroids, Colony Formation Assays, and Zebrafish Xenografts
Published on: June 26, 2018
New Coumarins from Pilocarpus goudotianus
J M Amaro-Luis1, G M Massanet, E Pando
1Institute de Investigatión Quimica, Facultad de Farmacia, Universidad de los Andes, Apdo. 142, Merida, Venezuela.
Researchers identified three novel coumarins, donatin, alloxanthoxyletol, and (+)-elisin, from Pilocarpus goudotianus leaves. Their structures were confirmed using spectroscopic data and chemical analysis.
Area of Science:
- Phytochemistry
- Natural Product Chemistry
- Organic Chemistry
Background:
- Pilocarpus species are known sources of bioactive compounds.
- Coumarins are a diverse class of natural products with various pharmacological properties.
- Exploration of Pilocarpus goudotianus secondary metabolites is ongoing.
Purpose of the Study:
- To isolate and characterize new coumarins from the leaves of Pilocarpus goudotianus.
- To elucidate the chemical structures of novel compounds using spectroscopic and chemical methods.
Main Methods:
- Phytochemical investigation of Pilocarpus goudotianus leaf extract.
- Isolation of compounds using chromatographic techniques.
- Structure elucidation through spectroscopic methods (NMR, MS) and chemical derivatization.
Main Results:
- Three new coumarins, named donatin, alloxanthoxyletol, and (+)-elisin, were isolated.
- Eight known coumarins were also identified.
- The structures of the new coumarins were fully elucidated.
Conclusions:
- The study expands the knowledge of coumarin diversity in the Pilocarpus genus.
- Donatin, alloxanthoxyletol, and (+)-elisin represent novel additions to the coumarin family.
- The findings contribute to the chemotaxonomic understanding of Pilocarpus species.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiasthma Drugs: Muscarinic Receptor Antagonists
Antimuscarinic agents compete with ACh for the same binding site on the muscarinic receptors. By binding to these receptors, they inhibit the downstream effects of ACh and block the parasympathetic...
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
